Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.
作者信息
Portales-Castillo Ignacio, Allegretti Andrew S
机构信息
Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Kidney360. 2020 Dec 31;1(12):1334-1336. doi: 10.34067/KID.0006212020.
Abstract
摘要
相似文献
1
Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.COVID-19 中的透析滤器寿命：疫情早期的经验教训
Kidney360. 2020 Dec 31;1(12):1334-1336. doi: 10.34067/KID.0006212020.
2
Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.急性肾损伤危重症患者的最佳清除模式（OMAKI）——血液滤过与血液透析对比的一项初步随机对照试验：加拿大重症监护试验组项目
Crit Care. 2012 Oct 24;16(5):R205. doi: 10.1186/cc11835.
3
Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.Cov-hep 研究：COVID-19 患者连续静脉-静脉血液透析中基于柠檬酸盐的标准抗凝方案中肝素的应用：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0.
4
Filter clotting with continuous renal replacement therapy in COVID-19.COVID-19中连续性肾脏替代疗法的滤器凝血
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
5
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.儿童 2019 冠状病毒病急性肾损伤及肾脏替代治疗的特殊考虑：来自欧洲儿童和新生儿重症监护学会重症肾脏病学组的观点。
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
6
Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure.持续静静脉血液滤过：急性肾衰竭中持续动静脉血液滤过及血液透析滤过的替代方法
Am J Kidney Dis. 1991 Oct;18(4):451-8. doi: 10.1016/s0272-6386(12)80113-2.
7
CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.CVVHD 比预滤 CVVH 更能延长滤器寿命：一项准随机临床试验结果。
PLoS One. 2023 Jan 11;18(1):e0278550. doi: 10.1371/journal.pone.0278550. eCollection 2023.
8
Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.急性肾衰竭患者通过传统间歇性血液透析、持续性低效透析或连续性静脉-静脉血液滤过清除利奈唑胺的情况。
Crit Care Med. 2004 Dec;32(12):2437-42. doi: 10.1097/01.ccm.0000147687.06808.92.
9
Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.在纽约市贝尔维尤医院治疗 COVID-19 大流行期间的急性腹膜透析。
Kidney360. 2020 Oct 16;1(12):1345-1352. doi: 10.34067/KID.0005192020. eCollection 2020 Dec 31.
10
Phenytoin removal by continuous venovenous hemofiltration.连续静脉-静脉血液滤过清除苯妥英钠。
Ann Pharmacother. 2013 Sep;47(9):1218-22. doi: 10.1177/1060028013503131.
引用本文的文献
1
Coagulation Risk Predicting in Anticoagulant-Free Continuous Renal Replacement Therapy.无抗凝剂持续肾脏替代治疗中的凝血风险预测
Blood Purif. 2024;53(11-12):916-927. doi: 10.1159/000540695. Epub 2024 Aug 12.
2
Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases.针对新冠肺炎细胞因子风暴：不对称醋酸纤维素在线血液透析滤过在维持性血液透析患者中的作用——10例报告
Case Rep Nephrol. 2021 Mar 12;2021:5575928. doi: 10.1155/2021/5575928. eCollection 2021.
本文引用的文献
1
Dialysis Filter Life, Anticoagulation, and Inflammation in COVID-19 and Acute Kidney Injury.COVID-19与急性肾损伤中的透析滤器寿命、抗凝及炎症
Kidney360. 2020 Oct 20;1(12):1426-1431. doi: 10.34067/KID.0004322020. eCollection 2020 Dec 31.
2
Filter clotting with continuous renal replacement therapy in COVID-19.COVID-19中连续性肾脏替代疗法的滤器凝血
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
3
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.接受连续性肾脏替代治疗的COVID-19患者的抗凝策略与滤器寿命：单中心经验
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.
4
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.估算美国在 COVID-19 大流行期间连续肾脏替代疗法提供能力短缺。
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
5
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
6
Bleeding and Bleeding Risk in COVID-19.新型冠状病毒肺炎中的出血与出血风险
Semin Thromb Hemost. 2020 Oct;46(7):815-818. doi: 10.1055/s-0040-1713434. Epub 2020 Jun 8.
7
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.病例17 - 2020：一名患有新冠病毒病和急性肾损伤的68岁男性。
N Engl J Med. 2020 May 28;382(22):2147-2156. doi: 10.1056/NEJMcpc2002418. Epub 2020 May 13.
8
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
9
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.感染新型冠状病毒（SARS-CoV-2）患者的血栓栓塞事件及明显的肝素抵抗
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):19-20. doi: 10.1111/ijlh.13230.
10
Thromboinflammation and the hypercoagulability of COVID-19.新冠病毒感染的血栓炎症与高凝状态
J Thromb Haemost. 2020 Jul;18(7):1559-1561. doi: 10.1111/jth.14849. Epub 2020 May 26.
Zotero 插件